Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
179.76
Dollar change
-7.86
Percentage change
-4.19
%
IndexRUT P/E101.69 EPS (ttm)1.77 Insider Own15.47% Shs Outstand28.76M Perf Week-8.71%
Market Cap5.17B Forward P/E30.69 EPS next Y5.86 Insider Trans-4.30% Shs Float24.31M Perf Month3.07%
Income52.37M PEG- EPS next Q1.18 Inst Own94.30% Short Float14.82% Perf Quarter-2.41%
Sales241.52M P/S21.41 EPS this Y608.72% Inst Trans-2.00% Short Ratio15.63 Perf Half Y8.50%
Book/sh30.80 P/B5.84 EPS next Y111.94% ROA5.91% Short Interest3.60M Perf Year72.78%
Cash/sh20.46 P/C8.79 EPS next 5Y- ROE6.38% 52W Range100.98 - 219.34 Perf YTD44.90%
Dividend Est.- P/FCF89.05 EPS past 5Y- ROI5.87% 52W High-18.05% Beta0.80
Dividend TTM- Quick Ratio7.76 Sales past 5Y0.00% Gross Margin89.83% 52W Low78.02% ATR (14)7.41
Dividend Ex-Date- Current Ratio7.97 EPS Y/Y TTM233.16% Oper. Margin26.89% RSI (14)44.76 Volatility3.47% 4.59%
Employees229 Debt/Eq0.01 Sales Y/Y TTM2722.79% Profit Margin21.68% Recom1.00 Target Price208.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-67.48% Payout0.00% Rel Volume1.25 Prev Close187.62
Sales Surprise1.08% EPS Surprise-8.40% Sales Q/Q879.91% EarningsNov 04 BMO Avg Volume230.45K Price179.76
SMA20-3.83% SMA50-0.54% SMA2000.65% Trades Volume288,402 Change-4.19%
Date Action Analyst Rating Change Price Target Change
Aug-06-24Downgrade Citigroup Buy → Neutral $195 → $204
Nov-20-23Initiated Goldman Buy $160
Oct-24-23Initiated Cantor Fitzgerald Overweight $100
Oct-12-23Initiated Citigroup Buy $160
Sep-07-23Initiated Berenberg Buy $154
Apr-18-23Initiated Stifel Buy $102
Feb-28-23Upgrade Goldman Neutral → Buy $79 → $124
Aug-25-22Downgrade Goldman Buy → Neutral $74
Jan-18-22Initiated BofA Securities Buy $110
Jul-20-21Upgrade Goldman Neutral → Buy $73 → $90
Dec-04-24 11:30AM
Nov-27-24 07:00AM
Nov-12-24 07:00AM
Nov-06-24 07:00AM
Nov-05-24 02:52AM
02:04AM Loading…
02:04AM
Nov-04-24 09:10AM
08:00AM
Nov-01-24 09:02AM
08:30AM
Oct-28-24 10:01AM
07:00AM
Oct-18-24 12:00PM
Oct-16-24 03:02PM
Sep-21-24 10:50AM
01:12PM Loading…
Sep-18-24 01:12PM
Sep-13-24 07:00AM
Sep-06-24 07:00AM
Sep-03-24 12:20PM
Aug-28-24 07:00AM
07:00AM
Aug-07-24 12:00PM
Aug-06-24 03:48AM
Aug-05-24 12:59PM
12:53PM
09:15AM
08:00AM
Aug-01-24 08:00AM
Jul-26-24 08:00AM
Jul-18-24 08:50AM
06:33PM Loading…
Jun-25-24 06:33PM
Jun-21-24 12:16AM
Jun-11-24 02:45PM
Jun-07-24 06:09PM
Jun-05-24 07:00AM
Jun-03-24 04:30PM
04:17PM
May-23-24 12:20PM
11:07AM
May-15-24 07:00AM
May-08-24 07:00AM
May-07-24 11:08AM
03:03AM
12:46AM
May-06-24 12:53PM
09:31AM
09:10AM
08:35AM
08:00AM
May-03-24 08:40AM
May-02-24 07:00AM
Apr-26-24 07:00AM
Apr-23-24 09:35AM
Apr-22-24 07:00AM
Apr-17-24 08:50AM
Apr-04-24 07:00AM
Apr-01-24 08:50AM
Mar-27-24 07:44AM
Mar-26-24 07:00AM
Mar-14-24 08:50AM
Mar-08-24 12:20PM
12:00PM
12:00PM
Mar-02-24 12:00AM
Mar-01-24 07:31AM
Feb-28-24 11:07AM
07:00AM
Feb-27-24 08:50AM
Feb-26-24 11:28PM
09:25AM
08:31AM
08:00AM
Feb-20-24 07:00AM
Feb-13-24 07:00AM
Feb-08-24 07:00AM
Feb-01-24 07:00AM
Jan-24-24 11:01PM
Jan-04-24 07:00AM
Dec-20-23 12:00PM
Dec-19-23 07:00AM
Dec-10-23 11:59AM
Dec-07-23 07:03AM
Dec-05-23 09:55AM
Nov-27-23 07:00AM
Nov-21-23 08:21PM
Nov-10-23 06:55AM
Nov-09-23 07:00AM
Nov-07-23 10:26AM
03:22AM
Nov-06-23 08:03AM
07:00AM
Oct-30-23 03:46PM
07:00AM
Sep-28-23 07:00AM
Sep-21-23 09:00AM
Sep-13-23 05:01PM
Sep-07-23 07:00AM
Sep-05-23 07:00AM
Aug-22-23 11:56AM
Aug-21-23 11:04AM
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krishnan SumaPresident, R&DSep 12 '24Sale197.7725,0004,944,2371,562,262Sep 13 05:45 PM
Krishnan SumaPresident, R&DSep 12 '24Sale197.7625,0004,944,0391,500,882Sep 13 05:45 PM
Krishnan Krish SPresident and CEOSep 12 '24Sale197.7725,0004,944,2371,562,262Sep 13 05:44 PM
Krishnan Krish SPresident and CEOSep 12 '24Sale197.7625,0004,944,0391,500,882Sep 13 05:44 PM
SUMA KRISHNANDirectorSep 12 '24Proposed Sale198.7925,0004,969,750Sep 12 04:33 PM
KRISH KRISHNANDirectorSep 12 '24Proposed Sale198.7925,0004,969,750Sep 12 04:33 PM
Krishnan SumaPresident, R&DJun 11 '24Sale175.7725,0004,394,1611,587,262Jun 11 08:33 PM
Krishnan SumaPresident, R&DJun 11 '24Sale175.7625,0004,393,9011,525,882Jun 11 08:33 PM
Krishnan Krish SPresident and CEOJun 11 '24Sale175.7725,0004,394,1611,587,262Jun 11 08:31 PM
Krishnan Krish SPresident and CEOJun 11 '24Sale175.7625,0004,393,9011,525,882Jun 11 08:31 PM
Gangolli Julian SDirectorMay 20 '24Option Exercise22.7520,000455,00020,000May 22 06:17 PM
Gangolli Julian SDirectorMay 20 '24Sale164.1320,0003,282,6900May 22 06:17 PM
Krishnan SumaPresident, R&DMar 11 '24Sale170.9625,0004,274,0401,550,882Mar 11 08:27 PM
Krishnan SumaPresident, R&DMar 11 '24Sale170.9525,0004,273,6791,612,262Mar 11 08:27 PM
Krishnan Krish SPresident and CEOMar 11 '24Sale170.9625,0004,274,0401,550,882Mar 11 08:24 PM
Krishnan Krish SPresident and CEOMar 11 '24Sale170.9525,0004,273,6791,612,262Mar 11 08:24 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Option Exercise31.7710,000317,75017,936Mar 01 08:20 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Sale165.885,000829,41712,936Mar 01 08:20 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Option Exercise63.557,500476,62514,536Mar 01 08:16 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Sale166.057,5001,245,38112,936Mar 01 08:16 PM
Krishnan SumaPresident, R&DFeb 28 '24Option Exercise0.0012,50001,643,047Mar 01 08:13 PM
Krishnan SumaPresident, R&DFeb 28 '24Option Exercise0.007,50001,579,353Mar 01 08:13 PM
Krishnan Krish SPresident and CEOFeb 28 '24Option Exercise0.007,50001,579,353Mar 01 08:09 PM
Krishnan Krish SPresident and CEOFeb 28 '24Option Exercise0.0012,50001,643,047Mar 01 08:09 PM
ROMANO KATHRYNChief Accounting OfficerFeb 26 '24Option Exercise52.268,087422,62717,556Feb 28 09:33 PM
ROMANO KATHRYNChief Accounting OfficerFeb 27 '24Option Exercise52.261,91399,97312,936Feb 28 09:33 PM
ROMANO KATHRYNChief Accounting OfficerFeb 26 '24Sale136.918,0871,107,18012,556Feb 28 09:33 PM
Romano KathrynChief Accounting OfficerJan 22 '24Option Exercise52.262,500130,65015,056Jan 24 05:44 PM
Romano KathrynChief Accounting OfficerJan 22 '24Sale130.002,500325,00012,556Jan 24 05:44 PM
Krishnan SumaPresident, R&DDec 11 '23Sale105.6725,0002,641,6631,574,206Dec 12 05:23 PM
Krishnan SumaPresident, R&DDec 11 '23Sale105.6725,0002,641,6281,634,338Dec 12 05:23 PM
Krishnan Krish SPresident and CEODec 11 '23Sale105.6725,0002,641,6631,574,206Dec 12 05:17 PM
Krishnan Krish SPresident and CEODec 11 '23Sale105.6725,0002,641,6281,634,338Dec 12 05:17 PM